Name: UMIN ID:
Unique ID issued by UMIN | UMIN000021061 |
---|---|
Receipt number | R000023935 |
Scientific Title | Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction(KSCC 1601) |
Date of disclosure of the study information | 2016/02/16 |
Last modified on | 2021/01/07 10:59:59 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/02/16 18:53:29 | ||
2 | Update | 2016/02/24 18:57:19 | Acronym Acronym |
|
3 | Update | 2016/05/10 19:59:58 | Name of primary person or sponsor Organization Research ethics review Institutions |
|
4 | Update | 2016/08/16 09:41:11 | Institutions |
|
5 | Update | 2016/08/17 09:01:19 | Recruitment status |
|
6 | Update | 2017/02/16 20:43:17 | Institutions |
|
7 | Update | 2017/07/18 18:32:34 | Control |
|
8 | Update | 2019/01/06 17:14:00 | Recruitment status |
|
9 | Update | 2019/01/06 17:14:28 | Email |
|
10 | Update | 2019/08/02 17:10:08 | UMIN ID2 |
|
11 | Update | 2019/08/02 17:11:56 | UMIN ID2 |
|
12 | Update | 2020/02/19 12:09:59 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
13 | Update | 2020/02/19 12:11:09 | Number of participants that the trial has enrolled |
|
14 | Update | 2020/02/19 12:13:57 | Date of IRB |
|
15 | Update | 2021/01/07 10:59:59 | Recruitment status |